CLINICAL_TRIALS
trial_result
· 2011-01-05
Clinical Trial Update: A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion Formulations [Phase 3]
Summary
Phase 3 trial update assessing the skin safety of Testosterone MD-Lotion formulations in hypogonadism, with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Hypogonadism | Phase 3 | Status: COMPLETED | Results posted: 2011-01-05